Tarsus Pharmaceuticals Inc header image

Tarsus Pharmaceuticals Inc

TARS

Equity

ISIN null / Valor 57410241

NASDAQ (2025-12-19)

USD 81.40+5.06%

Tarsus Pharmaceuticals Inc
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Tarsus Pharmaceuticals Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative treatments for diseases with significant unmet medical needs. The company has gained recognition for its FDA-approved product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, which is the first treatment specifically approved for Demodex blepharitis, a condition affecting millions of patients. Tarsus is committed to expanding its pipeline with a focus on addressing large-scale diseases that currently have limited treatment options, thereby aiming to improve patient outcomes across various therapeutic areas.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

56.5%1Y

476%3Y

64.0%5Y

Performance

49.1%1Y

58.6%3Y

64.5%5Y

Volatility

3455 M

Market cap (USD)

820,448

Daily traded volume (Shares)

57.03 / 53.92

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

SNP Schneider-Neureither & Partner SE

SNP Schneider-Neureither & Partner SE Valor: 1060617

Annual Return

-50%0%+50%

Risk level

110

-0.52%EUR 77.00

Syzygy AG

Syzygy AG Valor: 1127753

Annual Return

-50%0%+50%

Risk level

110

-1.27%EUR 1.55

Kontron AG

Kontron AG Valor: 10395864

Annual Return

-50%0%+50%

Risk level

110

0.35%EUR 22.66

Booking Holdings Inc

Booking Holdings Inc Valor: 40656108

Annual Return

-50%0%+50%

Risk level

110

0.90%USD 5,393.74

Biotest AG

Biotest AG Valor: 325670

Annual Return

-50%0%+50%

Risk level

110

-0.63%EUR 31.40

Exelixis Inc

Exelixis Inc Valor: 1069927

Annual Return

-50%0%+50%

Risk level

110

4.06%USD 44.30

Five9 Inc

Five9 Inc Valor: 23875956

Annual Return

-50%0%+50%

Risk level

110

-2.24%USD 20.54

GDS Holdings Ltd

GDS Holdings Ltd Valor: 34354375

Annual Return

-50%0%+50%

Risk level

110

4.27%USD 35.93

Certara Inc

Certara Inc Valor: 58446660

Annual Return

-50%0%+50%

Risk level

110

2.14%USD 9.07

Natera Inc

Natera Inc Valor: 28447012

Annual Return

-50%0%+50%

Risk level

110

3.21%USD 231.96

SIX

FactSet

Clearbit

Logos provided by Clearbit